A complex biological system is often required to study the myriad of host-pathogen interactions associated with infectious diseases, especially since the current basis of biology has reached the molecular level. The use of animal models is important for understanding the very complex temporal relationships that occur in infectious disease involving the body, its neuroendocrine and immune systems and the infectious organism. Because of these complex interactions, the choice of animal model must be a thoughtful and clearly defined process in order to provide relevant, translatable scientific data and to ensure the most beneficial use of the animals. While many animals respond similarly to humans from physiological, pathological, and therapeutic perspectives, there are also significant species-by-species differences. A well- of animal models available to researchers. In certain cases, such as for new or emerging diseases for which human data are not available, the animal model is crucial for understanding the pathogenesis of the disease before the development of vaccines or therapeutics can even be considered. Beyond that, a well-designed animal model provides a sound basis for supporting good science and ensuring the most beneficial use of both animal and human resources. Animal models play an especially important role in infectious disease research because in many cases, the resultant disease is potentially lethal or permanently disabling and therefore does not readily lend itself to research using human subjects. Animal models are essential for scientific advancement in many areas of human health, but if they are not well characterized and understood, erroneous conclusions may be drawn, hindering scientific advancement and resulting in a waste of animal life. A well-designed animal model requires a thorough understanding of similarities and differences in the
1 Biomedical models simulate a normal or abnormal process in either an animal or a human. For infectious disease research, animal models are meant to emulate the biological phenomenon of interest for a disease occurring in humans.
In developing or choosing an animal model, it is necessary to first have an understanding of terminology commonly used when discussing animal models. Important parameters of animal models include the concepts of homology, analogy, and fidelity. Homology refers to morphological identity of corresponding parts with structural similarity descending from common form. Homologous models therefore have genetic similarity. The degree of genetic similarity required for a model to be considered homologous is variable. Analogy refers to the quality of resemblance or similarity in function or appearance, but not of origin or development.
Therefore, analogous models have functional similarity. In general, animal models exhibit both of these attributes to various degrees, and so may be considered a hybrid of these. Model fidelity refers to how closely the model resembles the human for the condition being investigated. 2 Another layer of fidelity also may be a measurement of how reproducible the data are within the model itself.
Other important concepts include one-to-one modeling and many-to-many modeling. These terms refer to the general approach to the modeling process itself and not the individual animal model.
In one-to-one modeling, the process that is being simulated in a particular animal has analogous features with the human condition. In many-to-many modeling, each component of a process is examined in many species at various hierarchical levels, such as system, organ, tissue, cell, and subcellular. 3 Many-to-many modeling is often used during the development of animal models, whereas one-to-one modeling is more suited for research when the animal model is already well characterized and validated for the specific biological phenomenon being investigated. 4 Conceptually, animal models may be described in a number of ways: 5, 6 Induced (experimental), spontaneous (natural), genetically modified, negative, orphan, and surrogate. However, these descriptive categories cannot be used as classifications because the descriptions are not exclusive and models may have properties of more than one of the descriptions. Furthermore, as the knowledge of the model and the disease process progresses, the descriptive category of the model may change. Each of these descriptive categories will be discussed in the following paragraphs.
Experimental animal models are models wherein a disease or condition is induced in animals by the scientist. The experimental manipulation can take many forms, including exposure to biological agents such as an infectious virus or bacteria, exposure to chemical agents such as a carcinogen, or even surgical manipulations to cause a condition. In many cases, this approach would allow the selection of almost any species to model the effect. For example, many biological toxins may be assayed for activity in invertebrates as well as vertebrates. 7, 8 The model selected would depend on the needs of the researcher. However, many biological agents are selective and cause species-specific responses. This is particularly true of infectious agents including bacteria and viruses. Many infectious agents are limited in the species that they can infect and in which they can cause disease. Some are restricted to a single known host, such as human immunodeficiency virus causing disease only in humans.
Thus, these models are restricted to animals that are susceptible to the induced disease or condition.
The spontaneous model is typically used in research on naturally occurring heritable diseases. There are hundreds of examples of this type of model, including models for cancer, inflammation, and diabetes. As the term "spontaneous" implies, these models require the disease to appear in the population spontaneously. These types of models are not limited to inherited disease but may also apply to inherited susceptibility to disease. For instance, susceptibility to type 1 diabetes is a heritable trait. The NOD strain of mouse also exhibits a heritable susceptibility to diabetes relative to most strains of mice and has been used as a spontaneous model for type 1 diabetes. 9 Although the appearance of diabetes in the NOD mouse is spontaneous, the occurrence of the disease is associated with environmental factors. Thus, the NOD mouse model is described as a spontaneous model because diabetes arises without experimental intervention, even though the disease is triggered by environmental factors.
Although spontaneous models are typically associated with genetically inherited diseases, some of these models may represent diseases for which the inducing agent, such as virus, bacterium, or chemical, has not been identified. Once the inducing agent has been identified and actually applied by the researcher, the model would be described as an induced model. An example would be type 1 diabetes, for which it has been demonstrated that viral infections can either destroy beta cells directly or induce an autoimmune response that destroys the cells. 10 If the researcher employs the virus to induce diabetes in the NOD mouse, then this becomes an experimental model.
The genetically modified animal model is one in which the animal has been selectively modified at the genetic level. Because these models are produced from manipulation by researchers, models using genetically modified animals are actually a special example of the experimental model. In the broadest sense, genetically modified models may result from breeding or chemically induced mutations.
These may also include animals that have been modified through the use of recombinant DNA -a subgroup of genetically modified animal models referred to as transgenic animal models. 17 Salmonella typhimurium in mice is used to model Salmonella typhi infection in humans, 18 or monkeypox virus is used to model smallpox due to the stringent restrictions on the access to or possession of variola virus and its strong tropism and resultant clinical disease only seen in humans. However, more subtle differences also apply such as a human pathogen adapted to infect the species used for the animal model. For instance, Ebola Zaire virus can infect and cause disease in mice and guinea pigs after it is serially passaged in these species. 19 The fact that the virus has to be adapted to the new host implies that the virus undergoes a change; the Ebola virus adapted to the mouse and guinea pig cannot be considered identical to the human virus and must be considered a surrogate agent.
More difficult to define are the unintentional changes that occur to a pathogen with the mere passaging of organisms in the labora- ease.
An animal model can be described more than one way. For example, the mouse used to analyze SEB can be described as a genetically modified, induced model. Alternatively, a model may be described in a different way depending on the experimental design.
For instance, the spontaneous mouse model for diabetes may be 4. Create a search strategy and review the literature of previous animal models. 5 . Create a biological information matrix.
6. Define unique research resources.
7. Identify preliminary animal models of choice.
8. Conduct research to fill critical gaps of knowledge in the biological information matrix for the preliminary animal models of choice.
9. Evaluate the validity of the animal models of choice.
10. Identify animal models of choice.
| DEFIN ING THE RESE ARCH OBJE CTIVE
A single model likely will not be applicable to every situation. The model of choice is the model that best addresses the study's research aim within the research constraints. Therefore, a first step in animal model development is to define explicitly the specific question the research needs to address. The next step is to determine what specific information must be provided by the animal model to accomplish the research objective. This information is critical and will
give direction to the remaining animal model development process.
| DEFIN ING IN TRINSIC FACTORS
Once the experimental need has been defined, the next step in estab- to the toxin's effect on the neurons, might be identified as follows:
1. Toxin/agent penetration/absorption and biological stability.
2. Toxin/agent persistence in circulation and transit to target tissues.
3. Toxin/agent binding and uptake into target tissues.
4. Toxin/agent mechanism of action in target tissues.
Superimposed on this simple linear view of the disease process is a complex interplay between the host and pathogen. The pathogen will significantly change its physiology and expression of virulence factors in response to interactions with the host, and the host will also change in response to the pathogen. For example, the host cells may produce specific receptors only after exposure to the pathogen. 20 In addition, invasion by the pathogen will prompt the host's innate and acquired immune responses. The pathogen must circumvent the host's resistance, including competitive exclusion by the normal microflora, assault by host factors such as antimicrobial peptides and enzymes, and destruction by the innate and acquired immune response. In some cases, this evasion of the immune response leads to misdirection and deregulation of the immune response, resulting in the host's immune response actually contributing to the pathogenesis of the disease.
As this interaction progresses, the invading organism will typically harness the cellular processes of the host to promote its own replication and may directly cause damage to the host's cells and tissues.
The ability of the host to respond to the pathogen in a manner that halts the infection determines the degree of the disease that the host will experience. Thus, virulence is not solely a property of the invading organism but, rather, an expression of the interaction of the pathogen with its host.
A model of disease attempts to mimic the host-pathogen interaction. Therefore, the combination of both the host and pathogen defines a model for a disease and collectively makes up the intrinsic factors of the model.
| DEFINING THE EXTRIN SIC FACTORS
Other useful parameters that are not intrinsic to the host-pathogen/ agent interaction, but that can affect the process, are known as 
| CREATE A SEARCH STRATEGY
A preliminary, brief review of the literature using freely accessed information may be necessary to confirm the relevant intrinsic and extrinsic factors identified previously. The preliminary review should include previous studies using animal models and human clinical data. This review will allow for development of a detailed search strategy. If there are no previous data on animal models used for the specific condition being modeled, it is reasonable to search for animal species that have been used for modeling similar conditions. Animals with a close phylogenetic relationship to humans, such as monkeys, should be considered because it is reasonable to assume they may have a higher degree of homology and therefore may respond in a more similar manner. However, caution must be exercised because analogy does not always follow homology. This is demonstrated in monkeys, which do not develop acquired immunodeficiency when infected with the human immunodeficiency virus. Instead, the more distantly related feline infected with the feline leukemia virus is considered a more appropriate model for AIDS in humans. As the matrix is filled in with discrete data, comparative analogies can be made between the different species and the human data.
The species that most accurately reflects the human condition of study is then identified on the basis of the current state of scientific knowledge. It may become apparent at this point that more than 1 species is needed to address the research objective accurately. In addition, the best animal to model a specific component in the disease process may be different than the animal species chosen to model the entire disease process. It is paramount that the model be judged by how well it can be applied to the specific research question, rather than how well the animal models the entire array of the disease process in humans. For instance, yeasts may not be used to model central nervous system dysfunction caused by prions because they do not have a central nervous system. However, yeasts are used to model the biology of prion infection and propagation. 23 
| DEFIN E RE SEARCH R ESOUR CES
In addition to the biological matrix of information, there are many other considerations that must be taken into account when choosing the animal model. Because of animal availability, suitable housing, or other restrictions, some animal models may not be feasible for a particular researcher. For these investigators, only the more distantly related animals, such as mice, rats, guinea pigs, and rabbits, may be available.
The researcher should prepare a list of unique resource requirements. ideal model, and these should be considered against the available resources of the researcher when selecting a model: 24, 25 1. Accurately mimic the desired function or disease: This is a fundamental cornerstone for extrapolation of data.
Exhibit the investigated phenomenon with relative frequency:
The phenomenon must be readily present to lend itself to unhindered scientific study. tern of deposition within the animal varies by particle size in the generated aerosol. A particle size of 1 lm provides a similar pattern of pulmonary particle deposition in the guinea pig, nonhuman primate, and human, but at 5 lm, the pulmonary particle deposition is much lower in the guinea pig. 26 Similar considerations are important for oral challenges, such as the effects of stomach pH in the fed and unfed animals and between the various species, or the gastric emptying time compared to the volume of the challenge dose. 27, 28 The different strains or isolates of agents, and the differences in their preparation, must also be considered when comparing data from different research experiments and making extrapolations. The human population is considered to be genetically limited relative to most other animals, with the members of a single tribe of monkeys demonstrating more genetic diversity than that observed for the whole of humankind. Nevertheless, there are known genetic differences in the human population that influence susceptibility to diseases. For instance, susceptibility to infection by Plasmodium vivax is dependent on the host expressing the Duffy blood type, which is the receptor in humans for that parasite. 31 Further, for every disease The understanding of the disease process is further complicated by the fact that there are variants for most pathogenic agents, and these variants are associated with different virulence potentials.
Realizing the large array of factors that influence disease, and the limited understanding of these factors, models have still been used to determine whether a disease-causing agent follows a similar pathological progression between species and how the steps in this process contribute to the disease. When the disease processes and host's responses are similar to that of humans, the model provides a reference to allow predictions of responses in humans. However, numerous examples exist of accepted models that failed to be predictive at some level. For example, lethality of Yersinia pestis to small rodents is considered indicative of the virulence of the bacteria;
however, strains of Y. pestis have been described that kill mice but do not cause disease in larger animals, including humans. 32 As another example, primates are considered to be predictive of infections with Ebola virus, yet the Reston strain of Ebola virus that causes disease and death in primates apparently does not cause disease in humans. 33 Therefore, the degree of accuracy of predictions based on animal models can only be definitively assessed by comparing to natural cases of human exposure.
| CONCLUSION
The significant effect that animal models have had in the study of infectious diseases is exemplified by the application of Koch's postulates early in the history of microbiology. 34 The continued use of animal models has been essential to achieving our present understanding of infectious diseases and has led to the discovery of novel 
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